BALLERUP, Denmark & DUBLIN--(BUSINESS WIRE)--#partnership--LEO Pharma, a global leader in medical dermatology, and ICON plc (NASDAQ: ICLR) today announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective, and...
SAN ANTONIO--(BUSINESS WIRE)--NuStar Energy L.P. (NYSE: NS) announced today that members of management will participate in meetings with members of the investment community at the Seventh Annual Mizuho Energy Summit on Monday, March 13, 2023 and Tuesday, March 14,...
TORONTO--(BUSINESS WIRE)--Magellan Aerospace Corporation (“Magellan” or the “Corporation”) released its financial results for the fourth quarter of 2022. All amounts are expressed in Canadian dollars unless otherwise indicated. The results are summarized as follows:
Three month period ended
December 31
Twelve month...
On the heels of its security-based swap dealer registration, Capitolis’ subsidiary has submitted an application to become a registered broker-dealer in anticipation of new products
NEW YORK--(BUSINESS WIRE)--Capitolis, the technology company reimagining financial markets, announced that its subsidiary, Capitolis Global...
– Clinical data submitted are consistent with global data and support enfortumab vedotin as a platinum-free option in patients with locally advanced or metastatic urothelial cancer who received prior treatment with a PD-1/L1 inhibitor and platinum-based chemotherapy –
TOKYO &...
The Italian flag carrier will be the first full service airline in Europe to join the ground-breaking programme by Inmarsat and European Space Agency (ESA)
LONDON--(BUSINESS WIRE)--Digitally-connected flights to and from Italy will be available from this summer, as ITA...
Job adverts written by ChatGPT are 40% more biased than those written by humans.
It’s particularly biased against neurodivergent people, people with physical disabilities and people from disadvantaged ethnic groups.
COPENHAGEN--(BUSINESS WIRE)--New research suggests we should use ChatGPT with caution, especially...
QIAGEN to develop PCR test to detect isocitrate dehydrogenase-1 (IDH1) mutations in AML patients to be used with Servier’s marketed and investigational targeted treatment
Test for blood and bone marrow samples to run on QIAGEN Rotor-Gene Q device
QIAGEN now working...
KYOTO, Japan--(BUSINESS WIRE)--Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (“Nidec”) would like to extend its deepest sympathy and condolences to the people of Turkey and Syria affected by the devastating earthquake that struck the region on February 6th. As...
Pooled analysis of safety data from 5 clinical studies in 189 patients constituting the largest ever ND4-LHON cohort treated with gene therapy
Confirmation of the long-term safety profile of intravitreal injections of LUMEVOQ® with data covering a 5-year period following...